GRAZIANO SEGHEZZI

Graziano Seghezzi stands as a prominent figure in the European life sciences venture capital landscape, serving as a Managing Partner at Sofinnova Partners. Based in Paris, Sofinnova Partners is recognized as one of Europe's leading venture capital firms, exclusively dedicated to investing in breakthrough innovations across the life sciences sector. Seghezzi's leadership is pivotal in shaping the firm's investment strategy and fostering the growth of pioneering companies that address critical unmet medical needs.

His investment focus at Sofinnova Partners is deeply rooted in his extensive scientific background. Seghezzi primarily targets early-stage and growth-stage companies within biotechnology, pharmaceuticals, medical devices, and increasingly, digital health. He is particularly adept at identifying promising scientific discoveries with the potential to revolutionize patient care. His approach combines rigorous scientific due diligence with a keen understanding of market dynamics, enabling him to back ventures that are not only scientifically sound but also possess strong commercial viability. He plays a crucial role in transforming innovative research into tangible therapeutic solutions and successful enterprises.

Seghezzi's career trajectory is marked by a unique blend of scientific expertise and financial acumen. Before joining Sofinnova Partners in 2006, he honed his skills as a scientist at the prestigious European Institute of Oncology in Milan. There, his research focused on molecular biology, providing him with an invaluable foundational understanding of biological processes and drug discovery. This hands-on scientific experience distinguishes his investment philosophy, allowing him to deeply evaluate the scientific merits and risks of potential portfolio companies. He holds a Ph.D. in Molecular Biology from the University of Milan and further bolstered his business understanding with a Master's in Health Economics from the University of Siena.

Throughout his tenure at Sofinnova Partners, Graziano Seghezzi has been instrumental in identifying, nurturing, and scaling numerous successful life sciences companies. While specific individual investments are often a collective effort within the firm, his contributions have been vital to many of Sofinnova's significant achievements. He frequently serves on the boards of portfolio companies, providing strategic guidance and leveraging his vast network to accelerate their development. His leadership has contributed to successful IPOs and strategic acquisitions of companies developing innovative treatments and technologies, solidifying Sofinnova Partners' reputation as a powerhouse in life sciences investing. Graziano Seghezzi continues to drive innovation, supporting entrepreneurs who are at the forefront of medical advancement and shaping the future of healthcare.